BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ban M, Kitajima Y. Nail discoloration occurring after 8 weeks of minocycline therapy. J Dermatol 2007;34:699-701. [PMID: 17908141 DOI: 10.1111/j.1346-8138.2007.00362.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Piraccini BM. Drug-induced Nail Disorders. Baran & Dawber's Diseases of the Nails and their Management 2018. [DOI: 10.1002/9781119323396.ch16] [Reference Citation Analysis]
2 Fernandez-Flores A, Bermúdez CF, Molina I, Saus C, Monteagudo C, Cassarino DC. Pigmented Deposits in the Skin. Am J Dermatopathol 2018;40:307-28. [PMID: 29683860 DOI: 10.1097/DAD.0000000000000944] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
3 Yost JM. Nail Reactions to Antibiotics, Antimalarials, and Other Medications. Scher and Daniel's Nails 2018. [DOI: 10.1007/978-3-319-65649-6_28] [Reference Citation Analysis]
4 Hinshaw M. Non Melanocytic Pigment Abnormalities. Scher and Daniel's Nails 2018. [DOI: 10.1007/978-3-319-65649-6_19] [Reference Citation Analysis]
5 Aldunce-soto MJ, Soto Paredes R, Sánchez-regaña M, Salleras Redonnet M. Alteraciones ungueales inducidas por fármacos. Piel 2016;31:189-197. [DOI: 10.1016/j.piel.2015.06.017] [Reference Citation Analysis]
6 Minocycline. Meyler's Side Effects of Drugs 2016. [DOI: 10.1016/b978-0-444-53717-1.01089-1] [Reference Citation Analysis]
7 Haenssle HA, Brehmer F, Zalaudek I, Hofmann-Wellenhof R, Kreusch J, Stolz W, Argenziano G, Blum A. [Dermoscopy of nails]. Hautarzt 2014;65:301-11. [PMID: 24668319 DOI: 10.1007/s00105-013-2707-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 3] [Article Influence: 1.9] [Reference Citation Analysis]
8 Haenssle HA, Blum A, Hofmann-Wellenhof R, Kreusch J, Stolz W, Argenziano G, Zalaudek I, Brehmer F. When all you have is a dermatoscope- start looking at the nails. Dermatol Pract Concept. 2014;4:11-20. [PMID: 25396079 DOI: 10.5826/dpc.0404a02] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
9 Zaiac MN, Walker A. Nail abnormalities associated with systemic pathologies. Clin Dermatol 2013;31:627-49. [PMID: 24079592 DOI: 10.1016/j.clindermatol.2013.06.018] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 5.1] [Reference Citation Analysis]
10 Koeppel M, Bonnet N, Berbis P. Reacciones adversas cutáneas a medicamentos. EMC - Dermatología 2014;48:1-10. [DOI: 10.1016/s1761-2896(14)66801-1] [Reference Citation Analysis]
11 Piraccini BM, Alessandrini A. Drug-related nail disease. Clinics in Dermatology 2013;31:618-26. [DOI: 10.1016/j.clindermatol.2013.06.013] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 4.1] [Reference Citation Analysis]
12 Zuckerman MD, Boyle KL, Rosenbaum CD. Minocycline toxicity: case files of the University of Massachusetts medical toxicology fellowship. J Med Toxicol 2012;8:304-9. [PMID: 22777680 DOI: 10.1007/s13181-012-0247-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
13 Lebrun-vignes B, Kreft-jais C, Castot A, Chosidow O; the French Network of Regional Centers of Pharmacovigilance. Comparative analysis of adverse drug reactions to tetracyclines: results of a French national survey and review of the literature: Comparative analysis of adverse drug reactions to tetracyclines. British Journal of Dermatology 2012;166:1333-41. [DOI: 10.1111/j.1365-2133.2012.10845.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 4.4] [Reference Citation Analysis]
14 Baran R, Fouilloux B, Robert C. Drug-induced Nail Changes. Baran & Dawber's Diseases of the Nails and their Management 2012. [DOI: 10.1002/9781118286715.ch8] [Reference Citation Analysis]
15 Birns J, Tzakas P, Chua E. Skin and nail pigmentation from long-term use of minocycline. European Geriatric Medicine 2012;3:51-52. [DOI: 10.1016/j.eurger.2011.11.006] [Reference Citation Analysis]
16 Takci Z, Ozoguz P. Nail discoloration due to tinzaparin sodium. Cutaneous and Ocular Toxicology 2012;31:332-4. [DOI: 10.3109/15569527.2011.647178] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
17 Lebrun-vignes B, Bris C, Lelièvre B, Diquet B. Ongles et médicaments. Revue Francophone des Laboratoires 2011;2011:77-81. [DOI: 10.1016/s1773-035x(11)70955-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
18 Midtvedt T. Penicillins, cephalosporins, other beta-lactam antibiotics, and tetracyclines. Side Effects of Drugs Annual 2010. [DOI: 10.1016/s0378-6080(10)32025-3] [Reference Citation Analysis]
19 John Wiley & Sons, Ltd.. Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidem Drug Safe 2008;17:i-xvi. [DOI: 10.1002/pds.1486] [Reference Citation Analysis]